Vitamin E transporters in cancer therapy

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Vitamin E isoforms possess significant antioxidant and anticancer properties.
• Their therapeutic efficacy is hindered by poor oral bioavailability, low solubility, and rapid metabolism.
• Multidrug resistance (MDR) in cancer treatment remains a significant clinical challenge.

Purpose of the Study:

• To review the anticancer activities of vitamin E family members.
• To explore the potential of vitamin E as a chemosensitizer to overcome MDR.
• To discuss vitamin E bioavailability, transport mechanisms, and advanced delivery systems.

Main Methods:

• Literature review of studies on vitamin E's anticancer effects.
• Analysis of research on vitamin E's interaction with drug transporters.
• Examination of novel formulation and delivery strategies for vitamin E.

Main Results:

• Vitamin E isoforms exhibit cytotoxic effects against breast, prostate, and colon cancer cells.
• Vitamin E and its derivatives can act as chemosensitizers, potentially reversing MDR.
• Understanding of vitamin E disposition and transport proteins is crucial for enhancing bioavailability.

Conclusions:

• Vitamin E holds promise as an adjuvant therapy in cancer treatment, particularly for overcoming MDR.
• Advanced delivery systems are essential to improve vitamin E's bioavailability and therapeutic effectiveness.
• Further research into vitamin E formulations could unlock its full potential in oncology.